HMGB1 and Cerebral ischemia: Furthermore,we confirm that the anti-HMGB1-SA passes the blood–brain barrierin ischemic/reperfusion model rats and suppresses the immune and inflammatoryresponses of cerebral ischemia/reperfusion injury in vivo (Scheme 1).